In order for cancer cells to develop into a severe tumor, they need to be able to escape attack by the patient's own immune system. This is why immunotherapeutic treatment that helps the immune system to find and fight cancer ...
Nov 5, 2021
0
1
Researchers at the University of British Columbia (UBC) and BC Cancer, in partnership with BC Children's Hospital Research Institute (BCCHR), have developed a new test to more easily diagnose medulloblastoma, the most common ...
Nov 1, 2021
0
12
Immunotherapy using checkpoint inhibitors can work well to treat cancer, but only a minority of patients respond to therapy. Researchers at the University of Alabama at Birmingham have now shown—in preclinical experiments—how ...
Oct 28, 2021
0
31
Breast cancer patients whose cancer spreads to the brain may soon have new treatment options, thanks to research led by CU Cancer Center member Diana Cittelly, Ph.D.
Sep 20, 2021
0
2
Researchers with the SWOG Cancer Research Network have found that patients with metastatic hormone receptor-positive breast cancer who have low activity levels of the enzyme sTK1 in their blood serum at the start of anti-estrogen ...
Sep 14, 2021
0
6
Gastrointestinal stroma tumors (GIST) are cancers that start in specialized nerve cells found in the digestive system, from the esophagus and stomach to the intestines and rectum.
Aug 24, 2021
0
364
Patients with metastatic melanoma that had relapsed on anti-PD-1 therapies or BRAF/MEK inhibitors did not respond as well to an investigational therapy that involves the adoptive cell transfer of tumor-infiltrating lymphocytes ...
Aug 19, 2021
0
47
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical ...
Aug 16, 2021
0
18
Remetinostat, a topical cream and first-in-class inhibitor of histone deacetylation, showed signs of clinical efficacy in patients with basal cell carcinoma, according to results from a phase II clinical trial published in ...
Aug 6, 2021
0
2
A biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients, according to a new study published in Clinical Cancer Research.
Jul 27, 2021
0
88
